date,title,source
Nov-01-18,Aevi Genomic Medicine: 3Q Earnings Snapshot,Associated Press
Nov-01-18,Aevi Genomic Medicine Reports Third Quarter 2018 Financial Results and Provides Business Update,PR Newswire
Nov-05-18,"GNMX: With ASCEND Enrollment Completed, Read-Out Expected In Q119",Zacks Small Cap Research
Nov-08-18,"Detailed Research: Economic Perspectives on Gogo, Aevi Genomic Medicine, PBF Energy, SiteOne Landscape Supply, Douglas Dynamics, and Dine Brands Global  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Nov-26-18,Aevi Genomic Medicine to Host KOL Breakfast to Discuss Diagnosis and Treatment Paradigms in ADHD,PR Newswire
Dec-20-18,4 Pharma Stocks Getting a Boost on Thursday (12/20/18),ACCESSWIRE
Jan-02-19,Aevi Genomic Medicine Announces Top-Line Results from Placebo-Controlled ASCEND Trial (Parts A & B) of AEVI-001 in Children with ADHD,PR Newswire
Jan-03-19,"The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen",Benzinga
